doxorubicin hydrochloride has been researched along with verapamil in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (86.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Jiang, HH; Kong, F; Lou, HX; Sun, B; Xi, GM; Yuan, HQ | 1 |
| Huang, W; Jiao, L; Liu, B; Qian, H; Qiu, Q; Zhao, T | 1 |
| Cui, J; Dai, Y; Huang, W; Liu, B; Pan, M; Qian, H; Qiu, Q; Shi, W; Wu, Y | 1 |
| Gu, X; Huang, Z; Lu, B; Luo, X; Peng, H; Peng, S; Ren, Z; Tang, X; Tian, J; Xue, R; Zhang, Y | 1 |
| Cui, J; Dai, Y; Huang, W; Li, Z; Pan, M; Qian, H; Qiu, Q; Shi, W; Zhang, B | 1 |
| Cui, J; Ghaleb, H; Huang, W; Jiao, L; Kairuki, M; Liao, C; Lin, H; Pan, M; Qian, H; Zhou, J | 1 |
| Kaur, R; Kumar, K; Manjal, SK; Rawal, RK | 1 |
| He, L; Li, X; Liu, F; Liu, L; Liu, T; Peng, Y | 1 |
| Chen, J; Feng, D; Gu, X; Jiang, Y; Li, C; Qu, Y; Yin, X | 1 |
| Bi, X; Cui, J; Gao, Y; Huang, W; Li, Z; Liu, C; Qian, H; Shi, W; Wang, G | 1 |
| Ai, W; Bao, N; Chen, H; Li, S; Li, W; Wang, S | 1 |
| Gao, Y; Li, YL; Lou, HX; Xie, F; Xu, K; Zhao, ZT | 1 |
| Cai, Z; Ghaleb, H; Huang, W; Jiang, Y; Liu, Y; Qian, H; Qiu, Q; Shi, W; Yin, Z; Zhang, P; Zhou, J; Zou, F | 1 |
| Chen, L; Sun, J; Wu, C; Zhang, J; Zhao, M; Zhong, H | 1 |
1 review(s) available for doxorubicin hydrochloride and verapamil
| Article | Year |
|---|---|
Recent synthetic and medicinal perspectives of tryptanthrin.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Apoptosis; Bacteria; Drug Resistance, Neoplasm; Humans; Quinazolines; Toxoplasma | 2017 |
14 other study(ies) available for doxorubicin hydrochloride and verapamil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Bisbibenzyl derivatives sensitize vincristine-resistant KB/VCR cells to chemotherapeutic agents by retarding P-gp activity.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bibenzyls; Catechols; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Ethers, Cyclic; Humans; Phenyl Ethers; Rhodamine 123; Stilbenes; Vincristine | 2010 |
Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Cell Line, Tumor; Cell Survival; Click Chemistry; Doxorubicin; Drug Design; Drug Resistance, Neoplasm; Humans; Isoquinolines; K562 Cells; Rhodamine 123; Structure-Activity Relationship; Triazoles | 2014 |
Design, synthesis and biological evaluation of LBM-A5 derivatives as potent P-glycoprotein-mediated multidrug resistance inhibitors.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Click Chemistry; Doxorubicin; Drug Design; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Neoplasms; Structure-Activity Relationship; Tetrahydroisoquinolines | 2016 |
Potent Inhibition of Nitric Oxide-Releasing Bifendate Derivatives against Drug-Resistant K562/A02 Cells in Vitro and in Vivo.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biphenyl Compounds; Cell Proliferation; Drug Resistance, Neoplasm; Heterografts; Humans; In Vitro Techniques; K562 Cells; Mice; Mice, Nude; Nitric Oxide | 2017 |
Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Doxorubicin; Drug Discovery; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; K562 Cells; Neoplasms; Niacinamide | 2017 |
Synthesis and biological evaluation of JL-A7 derivatives as potent ABCB1 inhibitors.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B; Carbon-13 Magnetic Resonance Spectroscopy; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Humans; Isoquinolines; Proton Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Triazoles | 2017 |
A novel delocalized lipophilic cation-chlorambucil conjugate inhibits P-glycoprotein in HepG2/ADM cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cations; Cell Line; Cell Survival; Chlorambucil; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Mice; Molecular Docking Simulation; Molecular Structure; NIH 3T3 Cells; Structure-Activity Relationship | 2017 |
Synthesis and biological evaluation of bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potential P-glycoprotein and tumor metastasis inhibitors.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azepines; Biphenyl Compounds; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; K562 Cells; Molecular Structure; Neoplasms; Structure-Activity Relationship | 2018 |
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as P-glycoprotein-mediated multidrug resistance inhibitors.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Fluorescent Dyes; Humans; Isoquinolines; K562 Cells; Molecular Docking Simulation; Quinolines; Rhodamine 123; Structure-Activity Relationship | 2018 |
The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dictamnus; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Furans; Humans; MCF-7 Cells; Molecular Structure; Quinolines; Structure-Activity Relationship; Tubulin | 2018 |
Cytotoxic p-Terphenyls from the Endolichenic Fungus Floricola striata.
Topics: Ascomycota; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Humans; Terphenyl Compounds | 2018 |
Exploration of novel phthalazinone derivatives as potential efflux transporter inhibitors for reversing multidrug resistance and improving the oral absorption of paclitaxel.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasm Proteins; Neoplasms; Paclitaxel | 2022 |
Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; DNA Topoisomerases, Type I; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Molecular Docking Simulation | 2022 |